Interrogating KRAS ON and OFF signatures to treat KRAS-driven cancers: how far can we get?
| Dates: | 26 February 2024 |
|---|
| Times: | 15:00 - 16:00 |
|---|
| What is it: | Talk |
|---|
| Organiser: | Faculty of Biology, Medicine and Health |
|---|
| Who is it for: | University staff, Adults, Alumni, Current University students, General public |
|---|
| Speaker: | Silve Vicent |
|---|
|
Dr Silve Vincent, Associate Professor at Center of Applied Medical Research in Paloma, will be joining us to deliver a guest talk on 26th February 2024, at 15:00-16:00 on 'Interrogating KRAS ON and OFF signatures to treat KRAS-driven cancers: how far can we get?
Hosted by Dr. Colin Lindsay at the Oglesby Lecture Theatre, at the Manchester Cancer Research Centre
Dr. Silve Vicent, a distinguished researcher at the University of Navarra, focuses on molecular targets in KRAS mutant tumors. His work has led to significant advancements in identifying therapeutic strategies for KRAS-driven cancers.
Notably, he has received prestigious awards such as the Leonardo Fellowship in 2018 and the IASLC Young Investigator Award in 2015.
Recently, Dr. Vicent joined Libera Bio's Scientific Advisory Board, where his insights are instrumental in pioneering novel therapeutic approaches for "undruggable" intracellular targets in cancer therapy.
Sign up to attend via TicketSource
Speaker
Silve Vicent
Role: Associate Professor at Center of Applied Medical Research
Travel and Contact Information
Find event
Oglesby (Main) Lecture Theatre
Manchester Cancer Research Centre (OCRB)
